Estimation of HIV-Testing Rates to Maximize Early Diagnosis-Derived Benefits at the Individual and Population Level

Abstract

BackgroundIn HIV infection, initiation of treatment is associated with improved clinical outcom and reduced rate of sexual transmission. However, difficulty in detecting infection in early stages impairs those benefits. We determined the minimum testing rate that maximizes benefits derived from early diagnosis.MethodsWe developed a mathematical model of HIV infection, diagnosis and treatment that allows studying both diagnosed and undiagnosed populations, as well as determining the impact of modifying time to diagnosis and testing rates. The model’s external consistency was assessed by estimating time to AIDS and death in absence of treatment as well as by estimating age-dependent mortality rates during treatment, and comparing them with data previously reported from CASCADE and DHCS cohorts.ResultsIn our model, life expectancy of patients diagnosed before 8 years post infection is the same as HIV-negative population. After this time point, age at death is significantly dependent on diagnosis delay but initiation of treatment increases life expectancy to similar levels as HIV-negative population. Early mortality during HAART is dependent on treatment CD4 threshold until 6 years post infection and becomes dependent on diagnosis delay after 6 years post infection. By modifying testing rates, we estimate that an annual testing rate of 20% leads to diagnosis of 90% of infected individuals within the first 8.2 years of infection and that current testing rate in middle-high income settings stands close to 10%. In addition, many differences between low-income and middle-high incomes can be predicted by solely modifying the diagnosis delay.ConclusionsTo increase testing rate of undiagnosed HIV population by two-fold in middle-high income settings will minimize early mortality during initiation of treatment and global mortality rate as well as maximize life expectancy. Our results highlight the impact of achieving early diagnosis and the importance of strongly work on improving HIV testing rates.

Estimation of the HIV Incidence and of the Number of People Living With HIV/AIDS in Brazil, 2012

“…The current technological advances allow through rapid tests to find in a few minutes the HIV status of an individual [46]. But, it is still necessary to promote HIV testing, especially among most-at-risk groups.…”

Levels of alcohol use and history of HIV testing among female sex workers in Mombasa, Kenya

“…HIV testing is the critical first step to accessing HIV care and treatment (Dilernia et al, 2013; Kilmarx & Mutasa-Apollo, 2013). Timely linkage to care and early initiation of antiretroviral therapy (ART) are essential to achieve virologic suppression and reduction in HIV transmission (Cohen et al, 2011; Govindasamy et al, 2011; MacPherson et al, 2012; Rosen & Fox, 2011).…”

The Effect of a Local Change Team Intervention on Staff Attitudes Towards HIV Service Delivery in Correctional Settings: A Randomized Trial

“…There are significant individual and public health implications associated with gaps in the HIV/AIDS services treatment cascade (i.e., uninterrupted continuous engagement in HIV treatment; Dilernia et al, 2013; Gardner, McLees, Steiner, Del Rio, & Burman, 2011). Thus, there are substantial potential benefits associated with implementing improvements in services delivery within and between stakeholder agencies, especially continuous care during and beyond incarceration (Althoff et al, 2013; Booker at al., 2013; Gordon, Kinlock, McKenzie, Wilson, & Rich, 2013; Rapp et al, 2013).…”